Robert C. Stoner

Designs and develops oral small-molecule & injectable protein therapeutics

Smith Breeden Associates employs a variety of investment strategies including indexing, hedging, social screening and quantitative. Though not limited by sector or market-cap, the firm tends to invest in the stocks of companies in the finance, energy minerals, electronic technology, healthcare technology and consumer non-durables sectors. They invest globally, across all market-caps, with emphasis on the stocks of large-cap companies. SBA's fixed-income approach seeks to determine a fixed-income security's relative value. The firm employs quantitative research to identify high credit quality investments with the potential to generate risk-adjusted returns in excess of market returns. Their primary determinant of relative value is the option-adjusted spread to US Treasuries. The firm's fixed-income investment strategy is designed to generate a consistent and predictable return over the client's preferred benchmark. SBA's strategy emphasizes sector and security selection, duration targeting and high credit quality. The firm uses proprietary models to project mortgage prepayments, to identify price options embedded in agency MBS and corporate bonds, to price corporate bond credit risk, as well as to predict the future returns of major asset classes.

Functions as a College/University

Manufactures pharmaceutical preparations